Discontinuation report DOXORUBICIN HYDROCHLORIDE INJECTION
| Report ID | 59179 |
| Drug Identification Number | 02375710 |
| Brand name | DOXORUBICIN HYDROCHLORIDE INJECTION |
| Common or Proper name | DOXORUBICIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DOXORUBICIN HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVESICAL |
| Packaging size | 25ML VIAL |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-01-01 |
| Remaining supply date | 2019-01-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-01-02 | English | Compare |
| v2 | 2018-08-27 | French | Compare |
| v1 | 2018-08-27 | English | Compare |
Showing 1 to 3 of 3